Ayano Annis

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis”.

A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis

Nature Communications(2022)10.1038/s41467-022-32043-3

N/A

0DataRank · unranked

29 citations

Claire Johnson, Alan A. Schmalstig, Ayano Annis, Sarah E. Wessel, Brian Van Horn +8 more

Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid Formulations

Molecular Pharmaceutics(2023)10.1021/acs.molpharmaceut.3c00199

N/A

0DataRank · unranked

3 citations

Patrick O. Hanafin, Brittany K. Miller, Laura Rank, Sebastian Murcia, Christian Xander +11 more

Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus

Tuberculosis(2024)10.1016/j.tube.2024.102500

N/A

0DataRank · unranked

5 citations

Aaron Goff, David Wild, Ying Ding, Ayano Annis, Randy Kerber +10 more